Gainers

• Pomdoctor (NASDAQ:POM) stock moved upwards by 115.1% to $1.43 during Wednesday's regular session. The market value of their outstanding shares is at $4.9 million.
• Stablecoin Development (AMEX:SDEV) stock rose 43.97% to $1.2. The company's market cap stands at $22.7 million.
• PDS Biotechnology (NASDAQ:PDSB) shares increased by 31.12% to $1.26. The market value of their outstanding shares is at $66.4 million.
• Estrella Immunopharma (NASDAQ:ESLA) shares moved upwards by 22.77% to $0.49. The market value of their outstanding shares is at $16.5 million.
• Cypherpunk Technologies (NASDAQ:CYPH) shares increased by 20.28% to $3.38. The market value of their outstanding shares is at $272.6 million.
• ProMIS Neurosciences (NASDAQ:PMN) stock increased by 16.68% to $9.44. The market value of their outstanding shares is at $73.8 million.

Losers

• SCWorx (NASDAQ:WORX) stock fell 30.1% to $2.56 during Wednesday's regular session.
• Alpha Teknova (NASDAQ:TKNO) shares declined by 25.04% to $5.54. The company's market cap stands at $365.0 million.
• GT Biopharma (NASDAQ:GTBP) stock fell 24.22% to $5.54. The market value of their outstanding shares is at $12.0 million.
• DarioHealth (NASDAQ:DRIO) stock declined by 20.72% to $3.23. The market value of their outstanding shares is at $43.9 million.
• Lakewood-Amedex (NASDAQ:LABT) stock declined by 20.3% to $0.46. The market value of their outstanding shares is at $1.3 million.
• Circle8 Group (NASDAQ:CIRC) stock decreased by 16.65% to $0.33. The market value of their outstanding shares is at $39.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.